• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH ENZYMATIC HEMOGLOBIN A1C (A1C_E); HEMOGLOBIN A1C TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH ENZYMATIC HEMOGLOBIN A1C (A1C_E); HEMOGLOBIN A1C TEST SYSTEM Back to Search Results
Model Number N/A
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/15/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An outside of the united states customer contacted a siemens customer care center (ccc) and reported that erroneous enzymatic hemoglobin a1c (a1c_e) results were obtained on multiple patient samples on an atellica ch 930 analyzer.Siemens healthcare diagnostics is investigating the event.
 
Event or Problem Description
The customer reported to siemens erroneously elevated hemoglobin a1c (a1c_e) results obtained on sixty-three (63) patient samples on an atellica ch 930 analyzer.The initial results were reported to the physician(s), who questioned the results.The samples were reprocessed on an alternate atellica ch 930 analyzer.The repeat results were considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the erroneous a1c results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH ENZYMATIC HEMOGLOBIN A1C (A1C_E)
Common Device Name
HEMOGLOBIN A1C TEST SYSTEM
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive po box 6101
registration # 2517506
newark DE 19714 6101
Manufacturer Contact
eiman sulieman
500 gbc drive
po box 6101
newark, DE 19714-6101
7372808688
MDR Report Key23956024
Report Number2432235-2026-00002
Device Sequence Number17577402
Product Code PDJ
UDI-Device Identifier00630414220505
UDI-Public(01)00630414220505(10)150365(17)260804
Combination Product (Y/N)N
Initial Reporter CountryDA
PMA/510(K) Number
K200256
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 06/10/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/04/2026
Device Model NumberN/A
Device Catalogue Number11097536
Device Lot Number150365
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/18/2025
Supplement Date Received by Manufacturer06/02/2026
Initial Report FDA Received Date01/05/2026
Supplement Report FDA Received Date06/10/2026
Date Device Manufactured08/22/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
2432235-06/08/2026-003-C
Patient Sequence Number1
Patient SexUnknown
-
-